Back to ACORN CAPITAL ADVISORS, LLC
Q3 2026 13F filing
Updated 6 days ago22 disclosed positions worth $364M
Portfolio value
$364M
Total holdings
22
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | C CG ONCOLOGY INC | $80.2M | 1.13M | 22.04% | — |
| 2 | U UROGEN PHARMA LTD | $67M | 1.65M | 18.40% | — |
| 3 | ? N/A PUMA BIOTECHNOLOGY INC | $41M | 4.13M | 11.27% | — |
| 4 | C CANDEL THERAPEUTICS INC | $36.5M | 3.50M | 10.03% | — |
| 5 | T TREVI THERAPEUTICS INC | $30.7M | 2.14M | 8.44% | — |
| 6 | H HELUS PHARMA INC. | $18.9M | 1.54M | 5.20% | — |
| 7 | J JADE BIOSCEINCES INC | $13.9M | 986.8K | 3.81% | — |
| 8 | B BICARA THERAPEUTICS | $12.4M | 668.4K | 3.42% | — |
| 9 | V VERASTEM INC | $11.8M | 1.47M | 3.25% | — |
| 10 | O ONKURE THERAPEUTICS INC | $7.8M | 2.84M | 2.13% | — |
| 11 | E EUGENE THERAPEUTICS | $7.6M | 3.81M | 2.09% | — |
| 12 | ? N/A AN2 THERAPEUTICS | $6.9M | 1.30M | 1.90% | — |
| 13 | A AURA BIOSCIENCES INC | $6.4M | 1.03M | 1.77% | — |
| 14 | T PROTARA THERAPEUTICS INC | $5.3M | 1.75M | 1.47% | — |
| 15 | A ANNEXON INC. | $4.8M | 1.14M | 1.32% | — |
| 16 | L LEONABIO, INC. | $4.1M | 1.14M | 1.12% | — |
| 17 | W WHITEHAWK THERAPEUTICS INC | $3.5M | 932.1K | 0.96% | — |
| 18 | Q Q32 BIO INC. | $1.8M | 216.2K | 0.49% | — |
| 19 | K KARYOPHARM THERAPEUTICS INC | $1.5M | 1.22M | 0.41% | — |
| 20 | J JASPER THERAPEUTICS | $834K | 1.44M | 0.23% | — |
| 21 | V YARROW BIOSCIENCES INC | $721K | 32.0K | 0.20% | — |
| 22 | ? N/A BIOATLA INC | $141K | 108.1K | 0.04% | — |